Data as of Apr 16
| +0.21 / +0.87%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 32.50, with a high estimate of 35.00 and a low estimate of 14.00. The median estimate represents a +32.76% increase from the last price of 24.48.
The current consensus among 10 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.